UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 27, 2013
ARTHROCARE CORPORATION
(Exact name of registrant as specified in charter)
|
Delaware |
|
001-34607 |
|
94-3180312 |
|
(State or Other Jurisdiction of |
|
(Commission File Number) |
|
(I.R.S. Employer Identification |
7000 West William Cannon, Building One
Austin, TX 78735
(Address of principal executive offices, including zip code)
(512) 391-3900
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
As previously reported, in connection with the cooperation by ArthroCare Corporation (the “Company”) with the ongoing investigation by the U.S. Department of Justice (the “DOJ”), the Company entered into a statute of limitations tolling agreement with the DOJ effective until February 1, 2013 and extended to March 1, 2013 by mutual agreement of the DOJ and the Company. On February 27, 2013, the DOJ and the Company mutually agreed to extend further the tolling of the statute of limitations to March 30, 2013. At this stage of the ongoing investigation by the DOJ, the Company cannot predict its ultimate outcome and is unable to estimate any potential liability the Company may incur.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
ARTHROCARE CORPORATION |
|
|
|
|
|
|
|
|
|
Date: February 27, 2013 |
By: |
/s/ Todd Newton |
|
|
|
Todd Newton |
|
|
|
Executive Vice President and Chief Financial Officer and Chief Operating Officer |